Botulinum neurotoxin should be offered as a treatment option for the treatment of spasticity in adults and children (Level A).
No takes yet. Share an insight, caveat, or question.
Simpson et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: